Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing: 1st Edition (Hardback) book cover

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

1st Edition

By Harry Yang

Chapman and Hall/CRC

386 pages | 30 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781498704151
pub: 2016-12-01
SAVE ~$22.00
$110.00
$88.00
x
eBook (VitalSource) : 9781315371726
pub: 2016-11-30
from $28.98


FREE Standard Shipping!

Description

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

Table of Contents

BACKGROUND. Introduction. ANALYTICAL METHOD. Statistical Methods for Analytical Procedure Development, Validation and Transfer. Parallelism Testing of Bioassay. Validation of Assay Linearity. ROCESS DEVELOPMENT. Residual Host Cell DNA Risk Assessment. Statistical Evaluations of Viral Clearance. Pre-filtration Bio-burden Testing. Process Validation and Verification. MANUFACTURING. Specifications.

About the Author

Harry Yang, Ph.D., is senior director and head of the Non-Clinical Biostatistics Group at MedImmune, the global biologics arm of AstraZeneca headquartered in Gaithersburg, Maryland.

About the Series

Chapman & Hall/CRC Biostatistics Series

Learn more…

Subject Categories

BISAC Subject Codes/Headings:
MAT029000
MATHEMATICS / Probability & Statistics / General
MED071000
MEDICAL / Pharmacology
MED090000
MEDICAL / Biostatistics